Why Covid Patients Who Could Most Benefit From Paxlovid Still Aren’t Getting It
Price worries, bureaucratic obstacles, and “I’m-over-covid-itis” slow uptake of a drug that’s complicated to take but often effective…
Read More
- Q4’s stasis provided a launchpad for publishers’ Q1 advertising businesses
- This Ramadan, group wants food in empty stomachs, not waste bins
